Match!

Strategic trends in the drug industry

Published on May 1, 2003in Drug Discovery Today6.88
· DOI :10.1016/S1359-6446(03)02690-4
Jürgen Drews2
Estimated H-index: 2
(Bear Stearns)
Abstract
Abstract The promise of genomics in drug discovery, which was eagerly embraced in the mid-1990s, has not yet been fulfilled. However, the influence of modern biology on drug discovery remains viable. The promise of genomics and biology should be put in context with the two central problems of drug discovery: the search for disease-related targets, and the study of drug–protein interactions and protein–protein interactions. The first tier of the biotechnology industry has now become the most productive segment of the drug industry. It combines a high degree of innovative spirit with solid pharmaceutical professionalism. Some biotechnology firms have succeeded in addressing unmet medical needs in technologically appealing ways. In their totality, these changes will deeply alter the nature and appearance of the drug industry.
  • References (14)
  • Citations (135)
References14
Newest
#1Bruce A. Luxon (SLU: Saint Louis University)H-Index: 7
#2Michael J. Grace (Schering-Plough)H-Index: 20
Last.Ronald Bordens (Schering-Plough)H-Index: 17
view all 4 authors...
Cited By135
Newest
#1Maximilian Benz (KIT: Karlsruhe Institute of Technology)
#2Mijanur Rahaman Molla (KIT: Karlsruhe Institute of Technology)
Last.Pavel A. Levkin (KIT: Karlsruhe Institute of Technology)
view all 5 authors...
#1John G. McCarron (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 24
#2Calum Wilson (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 7
Last.Matthew D. Lee (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 3
view all 6 authors...
#1Naiem T. Issa (GUMC: Georgetown University Medical Center)H-Index: 6
#2Stephen W. Byers (Georgetown University)H-Index: 43
Last.Sivanesan Dakshanamurthy (Georgetown University)H-Index: 23
view all 3 authors...
#1Natacha Cerisier (French Institute of Health and Medical Research)H-Index: 1
#2Leslie Regad (French Institute of Health and Medical Research)H-Index: 2
Last.Anne-Claude Camproux (French Institute of Health and Medical Research)H-Index: 13
view all 6 authors...
#1Georgi K. Kanev (VU: VU University Amsterdam)H-Index: 2
#2Albert J. Kooistra (VU: VU University Amsterdam)H-Index: 15
Last.C. de Graaf (VU: VU University Amsterdam)H-Index: 12
view all 4 authors...
View next paperExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settings